عاصم Aziz

Senior finance leader providing CFO-level leadership to client companies under J&G's secondment practice; concurrent engagements with Merak Capital and Barq.

• As seconded CFO to Barq, oversaw Finance, HR, Technology, and Operations; raised $1.5M and SAR 5M in a bridge round and led the turnaround to profitability within four months, driving roughly 6% month-over-month growth and structural OPEX reduction.

• As Finance Director for Merak Capital, oversaw $450M+ AUM across VC and PE funds, leading CAM/ILPA reporting, quarterly valuations, and performance tracking.

• Managed $15M+ budgets and $10M+ OPEX across engagements; advised on CAPEX, free-cash-flow strategy, and investment decisions.

• Ensured CMA and IFRS compliance and delivered investor reporting to funds and portfolio companies.

Concurrently advised multiple high-growth clients on a fractional basis during this period.

• Oversaw a portfolio of 75+ startups across Agritech, Edtech, Fintech, and e-commerce.

• Supported $10M+ in startup fundraising and built valuation frameworks and financial models.

• Secured $5M+ in international (Germany) grant funding and prepared founders to be investor-ready.

• Delivered CFO advisory across US, UAE, and Egypt entities; clients included Cartlow, TribeXDigital, Greenfields Agritech, and Suplyd.

• Led financial strategy and audit across US, UAE, and Egypt entities.

• Supported a $1.5M bridge round and led financial due diligence on two mergers.

• Built financial models and valuations for acquired companies; delivered board and investor reporting.

• Managed a CHF 10M+ budget across multi-country relief programs, including COVID-19 response.

• Oversaw Finance, Operations, Logistics, HR, IT, and Premises.

• Investigated 6 fraud cases (CHF 300K total) and strengthened governance and internal controls with Global Compliance.

• Managed a 25B JPY budget and full planning cycle (SRF, LRF, MRP) with rolling forecasts and variance analysis.

• Supported the $51B acquisition and integration of Shire Pharmaceuticals and regional product strategies.

• Improved cash conversion cycle by 30% (DSO to 23 days; DPO to 55 days).

• Managed a $20M overdraft facility, reducing fees to 1%; oversaw collections across 2, 000+ customers.

• Contributed to planning, budgeting, and profitability analysis supporting ~25% business growth.

Provided audit services for the following companies:

• United Sugar Company
• Db Schenker
• Drake & Scull
• Electrolux - Ideal standard
• Vodafone
• Commercial International Life Insurance
• EFG Hermes
• Citibank
• Commercial International Investment Company
• Magic Life Hotels
• Barclays
• HSBC
• Cairo Medical Center
• Int’l School of Choueifat
• AstraZeneca EMM